Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $5,500 | 2 | 72.6% |
| Travel and Lodging | $1,291 | 7 | 17.0% |
| Food and Beverage | $787.09 | 33 | 10.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $6,958 | 12 | $0 (2023) |
| Davol Inc. | $153.26 | 5 | $0 (2024) |
| Smith+Nephew, Inc. | $118.04 | 6 | $0 (2024) |
| Medline Industries, Inc. | $42.35 | 2 | $0 (2018) |
| Allergan Inc. | $36.74 | 2 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $33.60 | 2 | $0 (2017) |
| Shire North American Group Inc | $28.65 | 2 | $0 (2018) |
| LivaNova USA, Inc. | $26.53 | 1 | $0 (2019) |
| Innocoll Incorporated | $22.52 | 1 | $0 (2021) |
| Hydrofera LLC | $21.42 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.60 | 4 | Davol Inc. ($89.16) |
| 2023 | $6,862 | 11 | Intuitive Surgical, Inc. ($6,862) |
| 2022 | $67.59 | 4 | Smith+Nephew, Inc. ($34.82) |
| 2021 | $58.89 | 3 | Innocoll Incorporated ($22.52) |
| 2020 | $47.95 | 3 | Teva Pharmaceuticals USA, Inc. ($18.13) |
| 2019 | $108.53 | 6 | Allergan Inc. ($36.74) |
| 2018 | $90.69 | 5 | Medline Industries, Inc. ($42.35) |
| 2017 | $195.01 | 6 | Intuitive Surgical, Inc. ($95.75) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | Smith+Nephew, Inc. | STRAVIX (Medical Supply) | Food and Beverage | In-kind items and services | $36.02 | General |
| Category: Extremities & Limb Restoration | ||||||
| 02/29/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Food and Beverage | In-kind items and services | $51.26 | General |
| Category: Surgery | ||||||
| 02/07/2024 | Davol Inc. | Tridyne Vascular Sealant (Device) | Food and Beverage | In-kind items and services | $37.90 | General |
| Category: Vascular/Oncology | ||||||
| 01/31/2024 | Hydrofera LLC | HYDROFERA BLUE (Device) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: WOUND CARE | ||||||
| 11/21/2023 | Intuitive Surgical, Inc. | DAVINCI XI (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 11/18/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $287.79 | General |
| Category: SURGERY | ||||||
| 11/16/2023 | Intuitive Surgical, Inc. | DAVINCI XI (Device) | Education | In-kind items and services | $2,500.00 | General |
| Category: SURGERY | ||||||
| 11/13/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $61.67 | General |
| Category: SURGERY | ||||||
| 11/13/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 10/30/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 10/03/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: SURGERY | ||||||
| 09/15/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $244.53 | General |
| Category: SURGERY | ||||||
| 09/01/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $639.66 | General |
| Category: SURGERY | ||||||
| 09/01/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 08/29/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $38.07 | General |
| Category: SURGERY | ||||||
| 07/20/2022 | Innocoll Pharmaceuticals Limited | XARACOLL (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Prescription Drug | ||||||
| 04/18/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/14/2022 | Smith+Nephew, Inc. | RENASYS GO v2 HOME (Device) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 01/26/2022 | Smith+Nephew, Inc. | RENASYS GO v2 HOME (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 12/16/2021 | Smith+Nephew, Inc. | STRAVIX (Medical Supply) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Extremities & Limb Restoration | ||||||
| 10/28/2021 | Innocoll Incorporated | XARACOLL (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: PAIN | ||||||
| 02/03/2021 | KCI USA, Inc. | PREVENA (Device), SNAP, V.A.C. VERAFLO CLEANSE CHOICE | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 10/07/2020 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $13.58 | General |
| 06/10/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Central Nervous System | ||||||
| 02/05/2020 | Z-Medica, LLC | QUIKCLOT (Device) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Anesthesia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 224 | 228 | $89,788 | $20,432 |
| 2022 | 7 | 148 | 154 | $69,426 | $14,808 |
| 2021 | 10 | 243 | 256 | $119,107 | $22,600 |
| 2020 | 16 | 447 | 489 | $181,524 | $38,235 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 26 | 26 | $19,266 | $4,331 | 22.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $22,022 | $3,783 | 17.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $17,043 | $2,928 | 17.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $4,290 | $2,122 | 49.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 23 | 23 | $3,220 | $1,406 | 43.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $8,912 | $1,148 | 12.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $9,030 | $1,123 | 12.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $1,818 | $994.10 | 54.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 24 | $1,296 | $829.73 | 64.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 13 | $1,261 | $764.14 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $1,070 | $635.57 | 59.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 14 | $560.00 | $367.64 | 65.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 30 | 30 | $22,230 | $3,225 | 14.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 19 | 19 | $19,019 | $3,216 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $3,388 | $2,053 | 60.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $8,892 | $2,050 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 25 | $2,500 | $1,713 | 68.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $11,697 | $1,288 | 11.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 25 | $1,700 | $1,264 | 74.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 21 | 22 | $22,022 | $4,192 | 19.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 24 | 24 | $17,784 | $4,158 | 23.4% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 32 | 33 | $24,453 | $3,692 | 15.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 20 | 20 | $14,820 | $3,375 | 22.8% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 28 | 29 | $16,153 | $2,187 | 13.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 34 | $2,312 | $1,583 | 68.4% |
About Dr. Gregory Laffoon, MD
Dr. Gregory Laffoon, MD is a Surgery healthcare provider based in Searcy, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831155910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Laffoon, MD has received a total of $7,578 in payments from pharmaceutical and medical device companies, with $146.60 received in 2024. These payments were reported across 42 transactions from 18 companies. The most common payment nature is "Education" ($5,500).
As a Medicare-enrolled provider, Laffoon has provided services to 1,062 Medicare beneficiaries, totaling 1,127 services with total Medicare billing of $96,074. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location Searcy, AR
- Active Since 04/26/2006
- Last Updated 02/21/2020
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1831155910
Products in Payments
- DAVINCI XI (Device) $5,500
- Da Vinci Surgical System (Device) $1,458
- STRAVIX (Medical Supply) $56.25
- ARISTA AH FlexiTip (Device) $51.26
- DAV-Phasix (Device) $44.41
- Hyalomatrix Wound Device (Device) $42.35
- XARACOLL (Drug) $39.21
- Tridyne Vascular Sealant (Device) $37.90
- STRATTICE (Device) $36.74
- RENASYS GO v2 HOME (Device) $34.82
- GATTEX (Drug) $28.65
- VNS Therapy (Device) $26.53
- HYDROFERA BLUE (Device) $21.42
- OVERSTITCH (Device) $21.25
- PHASIX (Device) $19.69
- BILAYER WOUND MATRIX (BWM) (Device) $18.29
- AJOVY (Biological) $18.13
- SIVEXTRO (Drug) $16.99
- ZERBAXA (Drug) $16.61
- QUIKCLOT (Device) $16.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.